$6.58
0.213.3%
Ult. Agg.: Oct 28, 7:40 PM
Bolt Biotherapeutics (BOLT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-17.44 | $-3.45 | $-5.02 | $-5.26 |
| Actual | $-4.57 | $-4.31 | $-3.84 | $-3.72 |
| Surprise | +73.8% | -24.9% | +23.5% | +29.3% |
| Revenue | ||||
| Estimate | $700000 | $1.5M | $914350 | $712480 |
| Actual | $5000 | $26000 | $2.5M | $2.2M |
| Surprise | -99.3% | -98.3% | +173.4% | +204.4% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-3.43 | $-3.48 |
| Revenue | ||
| Consensus | $300000 | $300000 |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-4.57 | $-17.44 | 73.8 % |
| Q1 | May 12, 2026 | $-4.31 | $-3.45 | -24.9 % |
| Q4 | Mar 12, 2026 | $-3.84 | $-5.02 | 23.5 % |
| Q3 | Nov 12, 2025 | $-3.72 | $-5.26 | 29.3 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $5.00K | $700.00K | -99.3 % |
| Q1 | May 12, 2026 | $26.00K | $1.50M | -98.3 % |
| Q4 | Mar 12, 2026 | $2.50M | $914.35K | 173.4 % |
| Q3 | Nov 12, 2025 | $2.17M | $712.48K | 204.4 % |